FBLG · Company research
FibroBiologics, Inc. (FBLG): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
18records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| FibroBiologics (FBLG) Slips to $0.96 as Shares Test Key Support Zone - Rounding Bottom - https://www.dars.gov.et/ | FibroBiologics (FBLG) Slips to $0.96 as Shares Test Key Support Zone - Rounding Bottom https://www.dars.gov.et/ | View source ↗ | https://www.dars.gov.et/ | Oct 14, 2026 | neutral | 0 | 0.6 |
| Australia accepts a patent application for a method aimed at rebuilding spinal-disc cartilage. - Stock Titan | Australia accepts a patent application for a method aimed at rebuilding spinal-disc cartilage. Stock Titan | View source ↗ | Stock Titan | Oct 14, 2026 | neutral | 0 | 0.6 |
| FibroBiologics, Inc. SEC Filing (Oct 13, 2026) - Stock Titan | FibroBiologics, Inc. SEC Filing (Oct 13, 2026) Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| 125,000 restricted shares accompany FibroBiologics (FBLG)'s convertible debt offering. - Stock Titan | 125,000 restricted shares accompany FibroBiologics (FBLG)'s convertible debt offering. Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| FibroBiologics Raises Capital via Convertible Debenture Financing - The Globe and Mail | FibroBiologics Raises Capital via Convertible Debenture Financing The Globe and Mail | View source ↗ | The Globe and Mail | Oct 9, 2026 | neutral | 0 | 0.6 |
| A 15% discount accompanies FibroBiologics (FBLG)'s zero-interest debt deal. - Stock Titan | A 15% discount accompanies FibroBiologics (FBLG)'s zero-interest debt deal. Stock Titan | View source ↗ | Stock Titan | Oct 8, 2026 | neutral | 0 | 0.6 |
| A patent filing proposes cells to make weight-loss medicine inside the body - Stock Titan | A patent filing proposes cells to make weight-loss medicine inside the body Stock Titan | View source ↗ | Stock Titan | Oct 7, 2026 | neutral | 0 | 0.6 |
| Fibrobiologics Inc (FBLG-Q) Stock Price and News - The Globe and Mail | Fibrobiologics Inc (FBLG-Q) Stock Price and News The Globe and Mail | View source ↗ | The Globe and Mail | Oct 2, 2026 | neutral | 0 | 0.6 |
| A biotech's chief scientist invests about $0.5M in the company - Stock Titan | A biotech's chief scientist invests about $0.5M in the company Stock Titan | View source ↗ | Stock Titan | Sep 17, 2026 | neutral | 0 | 0.6 |
| FibroBiologics Adds Leigh Steinberg to Board for Growth - The Globe and Mail | FibroBiologics Adds Leigh Steinberg to Board for Growth The Globe and Mail | View source ↗ | The Globe and Mail | Aug 25, 2026 | neutral | 0 | 0.6 |
| Hundreds of millions face disc disease; FibroBiologics' patent pairs cannabidiol and cell therapy - Stock Titan | Hundreds of millions face disc disease; FibroBiologics' patent pairs cannabidiol and cell therapy Stock Titan | View source ↗ | Stock Titan | Aug 20, 2026 | neutral | 0 | 0.6 |
| FibroBiologics (NasdaqCM:FBLG) Stock Forecast & Analyst Predictions - Simply Wall Street | FibroBiologics (NasdaqCM:FBLG) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Aug 4, 2026 | neutral | 0 | 0.6 |
| FIBROBIOLOGICS ($FBLG) Releases Q2 2026 Earnings - Quiver Quantitative | FIBROBIOLOGICS ($FBLG) Releases Q2 2026 Earnings Quiver Quantitative | View source ↗ | Quiver Quantitative | Jul 31, 2026 | neutral | 0 | 0.6 |
| FBLG Forecast — Price Target — Prediction for 2027 - TradingView | FBLG Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 26, 2026 | neutral | 0 | 0.6 |
| Is FibroBiologics, Inc. (FBLG) Advancing Toward a Breakthrough Psoriasis Treatment With CYPS317 Data? - Yahoo Finance | Is FibroBiologics, Inc. (FBLG) Advancing Toward a Breakthrough Psoriasis Treatment With CYPS317 Data? Yahoo Finance | View source ↗ | Yahoo Finance | Jun 2, 2026 | neutral | 0 | 0.6 |
| FibroBiologics, Inc. Common Stock (FBLG) Stock Price: Oct 7 Close $1.14 - Gotrade | FibroBiologics, Inc. Common Stock (FBLG) Stock Price: Oct 7 Close $1.14 Gotrade | View source ↗ | Gotrade | Apr 1, 2026 | neutral | 0 | 0.6 |
| FibroBiologics, Inc. Announces Pricing of Public Offering for 2.27 Million Shares and Warrants - Quiver Quantitative | FibroBiologics, Inc. Announces Pricing of Public Offering for 2.27 Million Shares and Warrants Quiver Quantitative | View source ↗ | Quiver Quantitative | Apr 1, 2026 | neutral | 0 | 0.6 |
| $FBLG stock is down 40% today. Here's what we see in our data. - Quiver Quantitative | $FBLG stock is down 40% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Mar 30, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.